Trial intelligence / Profile preview

Evaluation of oral morphine drops in alcohol solution for dyspnea in terminal lung cancer patients

2007-005853-47Phase 4Terminated

Sponsor
Medicinsk afdeling
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of morphine in Dyspnoea (SOB) and bronchial carcinoma (2 arms), sponsored by Medicinsk afdeling. Primary endpoint: Dyspnea relief assessed by visual analog scale (VAS). Started Jan 2008; status: terminated.

02

Drugs

morphine
03

Conditions

Dyspnoea (SOB)bronchial carcinoma

Beyond the preview

Go deeper on 2007-005853-47.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005853-47.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call